A Randomized, Placebo Controlled, Double Blind, Multicenter Therapeutic Confirmatory Clinical Study for the Evaluation of the Efficacy and Safety of Avanafil in the Patients With Erectile Dysfunction.

Trial Profile

A Randomized, Placebo Controlled, Double Blind, Multicenter Therapeutic Confirmatory Clinical Study for the Evaluation of the Efficacy and Safety of Avanafil in the Patients With Erectile Dysfunction.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 May 2017

At a glance

  • Drugs Avanafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Acronyms ALERT
  • Most Recent Events

    • 28 Feb 2012 Results presented at the 27th Congress of the European Association of Urology.
    • 24 Apr 2010 Actual number of patients (208) added as reported by ClinicalTrials.gov record.
    • 24 Apr 2010 Actual end date (1 Nov 2009) added as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top